A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer

This publication has 14 references indexed in Scilit:

• Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
  Journal of Clinical Oncology, 1989
• Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
  Journal of Clinical Oncology, 1985
• Mitoxantrone: an overview of safety and toxicity
  Investigational New Drugs, 1985
• Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update
  Investigational New Drugs, 1985
• Mitoxantrone: An active new agent in the treatment of advanced breast cancer
  Cancer Chemotherapy and Pharmacology, 1984
• A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer
  Breast Cancer Research and Treatment, 1983
• Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trial
  Cancer, 1982
• Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
  New England Journal of Medicine, 1981
• Radionuclide angiography for the evaluation of anthracycline therapy.
  1978
• Response and survival in advanced breast cancer after two non-cross-resistant combinations.
  BMJ, 1976